共 34 条
THE PROGNOSTIC-SIGNIFICANCE OF DNA FLOW-CYTOMETRY IN BREAST-CANCER - RESULTS FROM 881 PATIENTS TREATED IN A SINGLE-CENTER
被引:51
作者:

CAMPLEJOHN, RS
论文数: 0 引用数: 0
h-index: 0
机构:
GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

ASH, CM
论文数: 0 引用数: 0
h-index: 0
机构:
GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

GILLETT, CE
论文数: 0 引用数: 0
h-index: 0
机构:
GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

RAIKUNDALIA, B
论文数: 0 引用数: 0
h-index: 0
机构:
GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

BARNES, DM
论文数: 0 引用数: 0
h-index: 0
机构:
GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

GREGORY, WM
论文数: 0 引用数: 0
h-index: 0
机构:
GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

RICHARDS, MA
论文数: 0 引用数: 0
h-index: 0
机构:
GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

MILLIS, RR
论文数: 0 引用数: 0
h-index: 0
机构:
GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND
机构:
[1] GUYS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND
关键词:
FLOW CYTOMETRY;
BREAST CANCER;
S-PHASE FRACTION;
PLOIDY;
PROGNOSIS;
D O I:
10.1038/bjc.1995.29
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
In this single-centre study of 881 patients, S-phase fraction (SPF) was shown to be a significant prognostic marker in terms of overall survival (OS), relapse-free survival (RFS) and survival after relapse (SAR). Further, SPF had independent prognostic significance when considering a range of other clinicopathological variables, namely tumour grade and stage, nodal status, patient age, tumour size, menstrual status and treatment details. For OS and RFS, SPF was the second strongest predictor of the clinical course of the disease after nodal status, and for SAR it was the strongest prognostic marker. SPF correlated positively with histological grade but was the stronger predictor of survival. The distribution of SPF values was markedly different for the two ploidy classes of tumour, with DNA aneuploid tumours having a significantly higher average SPF. However, SPF retained its independent prognostic ability when DNA diploid and aneuploid tumours were analysed separately, DNA ploidy itself also proved to be an independent prognostic marker but the survival difference between the two ploidy classes was much less than that seen for different levels of SPF. Tumours with several DNA aneuploid populations (multiploid tumours) tended to have a worse prognosis than other aneuploid tumours but this trend did not reach statistical significance. In this and other studies from this centre, SPF has proved to be a robust predictor of clinical outcome in carcinoma of the breast.
引用
收藏
页码:140 / 145
页数:6
相关论文
共 34 条
[21]
NODE NEGATIVE BREAST-CANCER
[J].
OREILLY, SM
;
RICHARDS, MA
.
BMJ-BRITISH MEDICAL JOURNAL,
1990, 300 (6721)
:346-348

OREILLY, SM
论文数: 0 引用数: 0
h-index: 0

RICHARDS, MA
论文数: 0 引用数: 0
h-index: 0
[22]
DNA INDEX, S-PHASE FRACTION, HISTOLOGICAL GRADE AND PROGNOSIS IN BREAST-CANCER
[J].
OREILLY, SM
;
CAMPLEJOHN, RS
;
BARNES, DM
;
MILLIS, RR
;
ALLEN, D
;
RUBENS, RD
;
RICHARDS, MA
.
BRITISH JOURNAL OF CANCER,
1990, 61 (05)
:671-674

OREILLY, SM
论文数: 0 引用数: 0
h-index: 0
机构:
ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND

CAMPLEJOHN, RS
论文数: 0 引用数: 0
h-index: 0
机构:
ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND

BARNES, DM
论文数: 0 引用数: 0
h-index: 0
机构:
ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND

MILLIS, RR
论文数: 0 引用数: 0
h-index: 0
机构:
ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND

ALLEN, D
论文数: 0 引用数: 0
h-index: 0
机构:
ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND

RUBENS, RD
论文数: 0 引用数: 0
h-index: 0
机构:
ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND

RICHARDS, MA
论文数: 0 引用数: 0
h-index: 0
机构:
ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND
[23]
NODE-NEGATIVE BREAST-CANCER - PROGNOSTIC SUBGROUPS DEFINED BY TUMOR SIZE AND FLOW-CYTOMETRY
[J].
OREILLY, SM
;
CAMPLEJOHN, RS
;
BARNES, DM
;
MILLIS, RR
;
RUBENS, RD
;
RICHARDS, MA
.
JOURNAL OF CLINICAL ONCOLOGY,
1990, 8 (12)
:2040-2046

OREILLY, SM
论文数: 0 引用数: 0
h-index: 0
机构: GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

CAMPLEJOHN, RS
论文数: 0 引用数: 0
h-index: 0
机构: GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

BARNES, DM
论文数: 0 引用数: 0
h-index: 0
机构: GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

MILLIS, RR
论文数: 0 引用数: 0
h-index: 0
机构: GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

RUBENS, RD
论文数: 0 引用数: 0
h-index: 0
机构: GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

RICHARDS, MA
论文数: 0 引用数: 0
h-index: 0
机构: GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND
[24]
PROLIFERATIVE ACTIVITY, HISTOLOGICAL GRADE AND BENEFIT FROM ADJUVANT CHEMOTHERAPY IN NODE POSITIVE BREAST-CANCER
[J].
OREILLY, SM
;
CAMPLEJOHN, RS
;
MILLIS, RR
;
RUBENS, RD
;
RICHARDS, MA
.
EUROPEAN JOURNAL OF CANCER,
1990, 26 (10)
:1035-1038

OREILLY, SM
论文数: 0 引用数: 0
h-index: 0
机构: GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

CAMPLEJOHN, RS
论文数: 0 引用数: 0
h-index: 0
机构: GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

MILLIS, RR
论文数: 0 引用数: 0
h-index: 0
机构: GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

RUBENS, RD
论文数: 0 引用数: 0
h-index: 0
机构: GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

RICHARDS, MA
论文数: 0 引用数: 0
h-index: 0
机构: GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND
[25]
DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES
[J].
PETO, R
;
PIKE, MC
;
ARMITAGE, P
;
BRESLOW, NE
;
COX, DR
;
HOWARD, SV
;
MANTEL, N
;
MCPHERSON, K
;
PETO, J
;
SMITH, PG
.
BRITISH JOURNAL OF CANCER,
1977, 35 (01)
:1-39

PETO, R
论文数: 0 引用数: 0
h-index: 0
机构: UNIV OXFORD, OXFORD, ENGLAND

PIKE, MC
论文数: 0 引用数: 0
h-index: 0
机构: UNIV OXFORD, OXFORD, ENGLAND

ARMITAGE, P
论文数: 0 引用数: 0
h-index: 0
机构: UNIV OXFORD, OXFORD, ENGLAND

BRESLOW, NE
论文数: 0 引用数: 0
h-index: 0
机构: UNIV OXFORD, OXFORD, ENGLAND

COX, DR
论文数: 0 引用数: 0
h-index: 0
机构: UNIV OXFORD, OXFORD, ENGLAND

HOWARD, SV
论文数: 0 引用数: 0
h-index: 0
机构: UNIV OXFORD, OXFORD, ENGLAND

MANTEL, N
论文数: 0 引用数: 0
h-index: 0
机构: UNIV OXFORD, OXFORD, ENGLAND

MCPHERSON, K
论文数: 0 引用数: 0
h-index: 0
机构: UNIV OXFORD, OXFORD, ENGLAND

PETO, J
论文数: 0 引用数: 0
h-index: 0
机构: UNIV OXFORD, OXFORD, ENGLAND

SMITH, PG
论文数: 0 引用数: 0
h-index: 0
机构: UNIV OXFORD, OXFORD, ENGLAND
[26]
ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN PATIENTS WITH AXILLARY NODE-POSITIVE BREAST-CANCER - AN UPDATE OF THE GUYS MANCHESTER TRIAL
[J].
RICHARDS, MA
;
OREILLY, SM
;
HOWELL, A
;
GEORGE, WD
;
FENTIMAN, IS
;
CHAUDARY, MA
;
CROWTHER, D
;
RUBENS, RD
.
JOURNAL OF CLINICAL ONCOLOGY,
1990, 8 (12)
:2032-2039

RICHARDS, MA
论文数: 0 引用数: 0
h-index: 0
机构: CHRISTIE HOSP & HOLT RADIUM INST, MANCHESTER M20 9BX, LANCS, ENGLAND

OREILLY, SM
论文数: 0 引用数: 0
h-index: 0
机构: CHRISTIE HOSP & HOLT RADIUM INST, MANCHESTER M20 9BX, LANCS, ENGLAND

HOWELL, A
论文数: 0 引用数: 0
h-index: 0
机构: CHRISTIE HOSP & HOLT RADIUM INST, MANCHESTER M20 9BX, LANCS, ENGLAND

GEORGE, WD
论文数: 0 引用数: 0
h-index: 0
机构: CHRISTIE HOSP & HOLT RADIUM INST, MANCHESTER M20 9BX, LANCS, ENGLAND

FENTIMAN, IS
论文数: 0 引用数: 0
h-index: 0
机构: CHRISTIE HOSP & HOLT RADIUM INST, MANCHESTER M20 9BX, LANCS, ENGLAND

CHAUDARY, MA
论文数: 0 引用数: 0
h-index: 0
机构: CHRISTIE HOSP & HOLT RADIUM INST, MANCHESTER M20 9BX, LANCS, ENGLAND

CROWTHER, D
论文数: 0 引用数: 0
h-index: 0
机构: CHRISTIE HOSP & HOLT RADIUM INST, MANCHESTER M20 9BX, LANCS, ENGLAND

RUBENS, RD
论文数: 0 引用数: 0
h-index: 0
机构: CHRISTIE HOSP & HOLT RADIUM INST, MANCHESTER M20 9BX, LANCS, ENGLAND
[27]
CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST-CANCER
[J].
RUBENS, RD
;
KNIGHT, RK
;
FENTIMAN, IS
;
HOWELL, A
;
CROWTHER, D
;
GEORGE, WD
;
HAYWARD, JL
;
BULBROOK, RD
;
CHAUDARY, M
;
BUSH, H
;
SELLWOOD, RA
;
HOWAT, JMT
.
LANCET,
1983, 1 (8329)
:839-843

RUBENS, RD
论文数: 0 引用数: 0
h-index: 0
机构: UNIV HOSP S MANCHESTER,DEPT MED ONCOL,MANCHESTER M20 8LR,LANCS,ENGLAND

KNIGHT, RK
论文数: 0 引用数: 0
h-index: 0
机构: UNIV HOSP S MANCHESTER,DEPT MED ONCOL,MANCHESTER M20 8LR,LANCS,ENGLAND

FENTIMAN, IS
论文数: 0 引用数: 0
h-index: 0
机构: UNIV HOSP S MANCHESTER,DEPT MED ONCOL,MANCHESTER M20 8LR,LANCS,ENGLAND

HOWELL, A
论文数: 0 引用数: 0
h-index: 0
机构: UNIV HOSP S MANCHESTER,DEPT MED ONCOL,MANCHESTER M20 8LR,LANCS,ENGLAND

CROWTHER, D
论文数: 0 引用数: 0
h-index: 0
机构: UNIV HOSP S MANCHESTER,DEPT MED ONCOL,MANCHESTER M20 8LR,LANCS,ENGLAND

GEORGE, WD
论文数: 0 引用数: 0
h-index: 0
机构: UNIV HOSP S MANCHESTER,DEPT MED ONCOL,MANCHESTER M20 8LR,LANCS,ENGLAND

HAYWARD, JL
论文数: 0 引用数: 0
h-index: 0
机构: UNIV HOSP S MANCHESTER,DEPT MED ONCOL,MANCHESTER M20 8LR,LANCS,ENGLAND

BULBROOK, RD
论文数: 0 引用数: 0
h-index: 0
机构: UNIV HOSP S MANCHESTER,DEPT MED ONCOL,MANCHESTER M20 8LR,LANCS,ENGLAND

CHAUDARY, M
论文数: 0 引用数: 0
h-index: 0
机构: UNIV HOSP S MANCHESTER,DEPT MED ONCOL,MANCHESTER M20 8LR,LANCS,ENGLAND

BUSH, H
论文数: 0 引用数: 0
h-index: 0
机构: UNIV HOSP S MANCHESTER,DEPT MED ONCOL,MANCHESTER M20 8LR,LANCS,ENGLAND

SELLWOOD, RA
论文数: 0 引用数: 0
h-index: 0
机构: UNIV HOSP S MANCHESTER,DEPT MED ONCOL,MANCHESTER M20 8LR,LANCS,ENGLAND

HOWAT, JMT
论文数: 0 引用数: 0
h-index: 0
机构: UNIV HOSP S MANCHESTER,DEPT MED ONCOL,MANCHESTER M20 8LR,LANCS,ENGLAND
[28]
INDICATORS OF PROGNOSIS IN NODE-NEGATIVE BREAST-CANCER
[J].
SIGURDSSON, H
;
BALDETORP, B
;
BORG, A
;
DALBERG, M
;
FERNO, M
;
KILLANDER, D
;
OLSSON, H
.
NEW ENGLAND JOURNAL OF MEDICINE,
1990, 322 (15)
:1045-1053

SIGURDSSON, H
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN

BALDETORP, B
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN

BORG, A
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN

DALBERG, M
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN

FERNO, M
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN

KILLANDER, D
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN

OLSSON, H
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN
[29]
PROGNOSTIC-SIGNIFICANCE OF PROLIFERATIVE ACTIVITY AND PLOIDY IN NODE-NEGATIVE BREAST CANCERS
[J].
SILVESTRINI, R
;
DAIDONE, MG
;
DELBINO, G
;
MASTORE, M
;
LUISI, A
;
DIFRONZO, G
;
BORACCHI, P
.
ANNALS OF ONCOLOGY,
1993, 4 (03)
:213-219

SILVESTRINI, R
论文数: 0 引用数: 0
h-index: 0
机构: CNR,CTR PATOL CELLULARE,I-20133 MILAN,ITALY

DAIDONE, MG
论文数: 0 引用数: 0
h-index: 0
机构: CNR,CTR PATOL CELLULARE,I-20133 MILAN,ITALY

DELBINO, G
论文数: 0 引用数: 0
h-index: 0
机构: CNR,CTR PATOL CELLULARE,I-20133 MILAN,ITALY

MASTORE, M
论文数: 0 引用数: 0
h-index: 0
机构: CNR,CTR PATOL CELLULARE,I-20133 MILAN,ITALY

LUISI, A
论文数: 0 引用数: 0
h-index: 0
机构: CNR,CTR PATOL CELLULARE,I-20133 MILAN,ITALY

DIFRONZO, G
论文数: 0 引用数: 0
h-index: 0
机构: CNR,CTR PATOL CELLULARE,I-20133 MILAN,ITALY

BORACCHI, P
论文数: 0 引用数: 0
h-index: 0
机构: CNR,CTR PATOL CELLULARE,I-20133 MILAN,ITALY
[30]
THE RELATIONSHIP BETWEEN HISTOLOGICAL GRADE, ESTROGEN-RECEPTOR STATUS, EVENTS AND SURVIVAL AT 8 YEARS IN THE NATO (NOLVADEX) TRIAL
[J].
SINGH, L
;
WILSON, AJ
;
BAUM, M
;
WHIMSTER, WF
;
BIRCH, IH
;
JACKSON, IM
;
LOWREY, C
;
PALMER, MK
.
BRITISH JOURNAL OF CANCER,
1988, 57 (06)
:612-614

SINGH, L
论文数: 0 引用数: 0
h-index: 0
机构: UNIV LONDON KINGS COLL HOSP,SCH MED & DENT,DEPT MORBID ANAT,DENMARK HILL,LONDON SE5 8RX,ENGLAND

WILSON, AJ
论文数: 0 引用数: 0
h-index: 0
机构: UNIV LONDON KINGS COLL HOSP,SCH MED & DENT,DEPT MORBID ANAT,DENMARK HILL,LONDON SE5 8RX,ENGLAND

BAUM, M
论文数: 0 引用数: 0
h-index: 0
机构: UNIV LONDON KINGS COLL HOSP,SCH MED & DENT,DEPT MORBID ANAT,DENMARK HILL,LONDON SE5 8RX,ENGLAND

WHIMSTER, WF
论文数: 0 引用数: 0
h-index: 0
机构: UNIV LONDON KINGS COLL HOSP,SCH MED & DENT,DEPT MORBID ANAT,DENMARK HILL,LONDON SE5 8RX,ENGLAND

BIRCH, IH
论文数: 0 引用数: 0
h-index: 0
机构: UNIV LONDON KINGS COLL HOSP,SCH MED & DENT,DEPT MORBID ANAT,DENMARK HILL,LONDON SE5 8RX,ENGLAND

JACKSON, IM
论文数: 0 引用数: 0
h-index: 0
机构: UNIV LONDON KINGS COLL HOSP,SCH MED & DENT,DEPT MORBID ANAT,DENMARK HILL,LONDON SE5 8RX,ENGLAND

LOWREY, C
论文数: 0 引用数: 0
h-index: 0
机构: UNIV LONDON KINGS COLL HOSP,SCH MED & DENT,DEPT MORBID ANAT,DENMARK HILL,LONDON SE5 8RX,ENGLAND

PALMER, MK
论文数: 0 引用数: 0
h-index: 0
机构: UNIV LONDON KINGS COLL HOSP,SCH MED & DENT,DEPT MORBID ANAT,DENMARK HILL,LONDON SE5 8RX,ENGLAND